Table 1 Clinical and physiological characteristics of patients with NAFLD or C-CH.

Gender (F/M)

19/18

17/23

ns

Age (yo)

54.4 ± 16.2

69.5 ± 9.5

<0.001

BMI (Kg/m²)

29.6 ± 7.3

24.0 ± 3.7

<0.001

FBS (mg/dl)

11.5 ± 29.8

113.4 ± 41.9

ns

f-IRI (μU/ml)

19.4 ± 17.1

11.1 ± 6.9

<0.05

HOMA-IR

5.15 ± 4.70

3.18 ± 2.22

<0.05

HbA1c (%)

6.3 ± 1.6

6.3 ± 1.3

ns

1,5-AG (μg/ml)

15.3 ± 7.6

15.3 ± 10.3

ns

AST (IU/L)

64.9 ± 26.7

55.8 ± 26.0

ns

ALT (IU/L)

89.7 ± 49.4

43.7 ± 22.9

<0.001

ALP (IU/L)

275.1 ± 69.8

387.8 ± 163.1

<0.001

GGT (IU/L)

101.5 ± 82.9

68.3 ± 75.7

ns

T-Bil (mg/dl)

0.93 ± 0.41

1.05 ± 0.85

ns

TP (g/dl)

7.4 ± 0.5

7.2 ± 0.7

ns

ALB (g/dl)

4.4 ± 0.5

3.5 ± 0.7

<0.001

T-CHO (mg/dl)

201.7 ± 33.4

149.9 ± 33.1

<0.001

TG (mg/dl)

152.5 ± 71.9

103.7 ± 50.1

<0.005

RBC (×10⁴/μl)

460.0 ± 52.1

384.3 ± 54.2

<0.001

Hb (g/dl)

14.3 ± 1.4

12.4 ± 1.7

<0.001

PLT (×10⁴/μl)

18.9 ± 6.9

12.8 ± 6.6

<0.001

WBC (×10³/μl)

6.0 ± 1.5

5.0 ± 2.0

<0.05

IV collagen 7S (ng/ml)

5.1 ± 2.1

8.8 ± 3.7

<0.001

P-3-P (U/ml)

0.7 ± 0.3

1.2 ± 0.3

<0.001

FIB-4 index

2.69 ± 2.07

6.69 ± 5.61

<0.001

PT (INR)

1.04 ± 0.08

1.16 ± 0.22

<0.005